Literature DB >> 31332712

Identification of gene co-expression modules and hub genes associated with lymph node metastasis of papillary thyroid cancer.

Tianyu Zhai1, Dilidaer Muhanhali1, Xi Jia2, Zhiyong Wu3, Zhenqin Cai1, Yan Ling4.   

Abstract

Papillary thyroid cancer (PTC) is the most prevalent histological type among thyroid cancers, and some patients are at a high risk for recurrent disease or even death. Identification for the potential biomarkers of PTC may contribute to early discovery of recurrence and treatment. In The Cancer Genome Atlas (TCGA) database, we obtained the information of RNA sequence data and clinical characteristics of PTC. Weighted gene co-expression network analysis (WGCNA) was performed to construct gene co-expression networks and investigate the relationship between modules and clinical traits. Finally, we constructed 16 co-expression modules in 10,428 genes, and three key modules (darkturquoise, lightyellow, and red) associated with tumor N grade were identified. The results of functional annotation indicated that the darkturquoise module was primarily enriched in the regulation of the extracellular matrix (ECM), collagen metabolism, and cell adhesion, the lightyellow module was primarily enriched in the mitochondrial function regulation and energy synthesis, and the red module was primarily enriched in the process of cell junction, apoptosis, and inflammatory response, suggesting their significant role in the progression of PTC. In addition, the hub genes in the three modules were identified and screened for differentially expressed genes (DEGs). Relapse-free survival analyses found that 11 genes (KCNQ3, MET, FN1, ITGA3, RUNX1, ITGA2, PERP, GCSH, FAAH, NGFRAP1, and HSPA5) may play a pivotal role in PTC relapse. In general, our research revealed the key co-expression modules and identified several prognostic biomarkers, which provides some new insights into the lymph node metastasis of PTC.

Entities:  

Keywords:  Hub genes; Lymph node metastasis; Papillary thyroid cancer; Weighted gene co-expression network analysis

Mesh:

Year:  2019        PMID: 31332712     DOI: 10.1007/s12020-019-02021-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

1.  Systematic determination of genetic network architecture.

Authors:  S Tavazoie; J D Hughes; M J Campbell; R J Cho; G M Church
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

2.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

Review 3.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 4.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

5.  TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression.

Authors:  Xiaomeng Li; Xianhui Ruan; Peitao Zhang; Yang Yu; Ming Gao; Shukai Yuan; Zewei Zhao; Jie Yang; Li Zhao
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

6.  Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007.

Authors:  Youxin Wang; Wei Wang
Journal:  Asia Pac J Public Health       Date:  2012-02-16       Impact factor: 1.399

7.  Key gene co-expression modules and functional pathways involved in the pathogenesis of Graves' disease.

Authors:  Xiaoqing Shao; Bin Wang; Kaida Mu; Ling Li; Qian Li; Weiwei He; Qiuming Yao; Xi Jia; Jin-An Zhang
Journal:  Mol Cell Endocrinol       Date:  2018-03-31       Impact factor: 4.102

8.  National cancer incidence and mortality in China, 2012.

Authors:  Wanqing Chen; Rongshou Zheng; Tingting Zuo; Hongmei Zeng; Siwei Zhang; Jie He
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

9.  Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts.

Authors:  Natallia Shved; Gregor Warsow; Felix Eichinger; David Hoogewijs; Simone Brandt; Peter Wild; Matthias Kretzler; Clemens D Cohen; Maja T Lindenmeyer
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

10.  Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome.

Authors:  Angela P Presson; Eric M Sobel; Jeanette C Papp; Charlyn J Suarez; Toni Whistler; Mangalathu S Rajeevan; Suzanne D Vernon; Steve Horvath
Journal:  BMC Syst Biol       Date:  2008-11-06
View more
  15 in total

1.  Identification of gene co-expression modules and hub genes associated with the invasiveness of pituitary adenoma.

Authors:  Yuancheng Zhou; Xiaorui Fu; Zhicheng Zheng; Yu Ren; Zijian Zheng; Bohan Zhang; Min Yuan; Jian Duan; Meihua Li; Tao Hong; Guohui Lu; Dongwei Zhou
Journal:  Endocrine       Date:  2020-04-27       Impact factor: 3.633

2.  Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.

Authors:  Qiang Li; Sheng Jiang; Tienan Feng; Tengteng Zhu; Biyun Qian
Journal:  Onco Targets Ther       Date:  2021-05-12       Impact factor: 4.147

3.  Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma.

Authors:  Hui-Yun Gu; Chao Zhang; Jia Guo; Min Yang; Hou-Cheng Zhong; Wei Jin; Yang Liu; Li-Ping Gao; Ren-Xiong Wei
Journal:  Aging (Albany NY)       Date:  2020-02-21       Impact factor: 5.682

4.  Circular RNA circRUNX1 promotes papillary thyroid cancer progression and metastasis by sponging MiR-296-3p and regulating DDHD2 expression.

Authors:  Junjie Chu; Li Tao; Teng Yao; Zizheng Chen; Xiaoxiao Lu; Li Gao; Liang Fang; Jian Chen; Gaofei He; Shuying Shen; Deguang Zhang
Journal:  Cell Death Dis       Date:  2021-01-21       Impact factor: 8.469

5.  A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.

Authors:  Jin-Ming Yao; Jun-Yu Zhao; Fang-Fang Lv; Xue-Bo Yang; Huan-Jun Wang
Journal:  Pathol Oncol Res       Date:  2022-02-23       Impact factor: 3.201

6.  ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma.

Authors:  Weigang Qiu; Xinquan Wu; Haihong Shi; Bingyang Liu; Liqiong Li; Wenyi Wu; Jianqing Lin
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

7.  Identification and validation of key modules and hub genes associated with the pathological stage of oral squamous cell carcinoma by weighted gene co-expression network analysis.

Authors:  Xuegang Hu; Guanwen Sun; Zhiqiang Shi; Hui Ni; Shan Jiang
Journal:  PeerJ       Date:  2020-02-04       Impact factor: 2.984

8.  Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis.

Authors:  Yang Liu; Ting-Yu Chen; Zhi-Yan Yang; Wei Fang; Qian Wu; Chao Zhang
Journal:  J Transl Med       Date:  2020-04-16       Impact factor: 5.531

9.  Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.

Authors:  Yuyang Tong; Peixuan Sun; Juanjuan Yong; Hongbo Zhang; Yunxia Huang; Yi Guo; Jinhua Yu; Shichong Zhou; Yulong Wang; Yu Wang; Qinghai Ji; Yuanyuan Wang; Cai Chang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

10.  A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.

Authors:  Mingjun Wang; Rongjing Li; Xiuhe Zou; Tao Wei; Rixiang Gong; Jingqiang Zhu; Zhihui Li
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.